A randomised controlled clinical study to evaluate the efficacy and quality of life of structured self glucose monitoring in non-insulin treated type 2 diabetes mellitus patients in Japan

A randomised controlled clinical study to evaluate the efficacy and quality of life of structured self glucose monitoring in non-insulin treated type 2 diabetes mellitus patients in Japan - Effect on Quality of life and Efficacy of STructured self glucose monitoring in non-insulin treated type 2 diabetes mellitus patients in Japan (QUEST)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008480

Enrollment

Registered

2012-07-20

Start date

2012-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

Nutritional consultation three times in first six months and ST-SMBG for a year Nutritional consultation three times in first six months without SMBG

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetes HbA1c within recent 2 months over 7%

Exclusion criteria

Exclusion criteria: Already treated by insulin Already performed SMBG Who cannot perform SMBG by some reason like dementia Pregnant Who have such diseases which affect the values of Hba1c as end-stage renal disease, liver cirrhosis, thyroid disease, and hematological disorders

Design outcomes

Primary

Measure	Time frame
HbA1c after 6 months and 12months	—

Secondary

Measure	Time frame
glycoalbumin after 6 months and 12months change of glycoalbumin/HbA1c ratio after 6 months and 12months change of BMI ratio after 6 months and 12months change of QOL after 6 months and 12months frequency and pattern of severe hypoglycemia frequency and pattern of fasting/postprandial hyperglycemia opinions against Accu-Chek&reg; 360 from study subjects and medical stuffs	—

Countries

Japan

Contacts

Public ContactShu Meguro

Keio University school of medicine Nephrology, endocrinology, and metabolism department

shumeg@z8.keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026